Esperion Therapeutics
ESPR
#6578
Rank
C$1.15 B
Marketcap
C$4.48
Share price
0.00%
Change (1 day)
205.62%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): C-$0.71

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.71. In 2024 the company made an earnings per share (EPS) of C-$0.33 an increase over its 2023 EPS that were of C-$3.02.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.71116.88%
2024C-$0.33-89.15%
2023C-$3.02-40.28%
2022C-$5.05-62.87%
2021C-$13.6180.38%
2020C-$7.5450.14%
2019C-$5.02-53.18%
2018C-$10.737.41%
2017C-$9.99110.81%
2016C-$4.7447.35%
2015C-$3.220.89%
2014C-$3.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.86-362.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$60.54-8,606.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.70 1,122.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.27-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.16-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$1.99-380.00%๐Ÿ‡บ๐Ÿ‡ธ USA